Dupuytren's Contracture
Also known as: Dupuytren's disease, Palmar fibromatosis, Viking disease
Dupuytren's contracture is a condition in which the layer of tissue beneath the skin of the palm (the palmar fascia) gradually thickens and tightens. It begins as small, firm nodules in the palm and over months or years can form cords that pull one or more fingers, most often the ring and little fingers, into a bent position that cannot be straightened. It is usually painless but makes activities such as putting on gloves, washing your face or placing your hand flat on a table difficult. The condition runs strongly in families and is most common in men of northern European descent over 50. Treatment ranges from watchful waiting for mild cases to needle release, enzyme injections or surgery when fingers become significantly bent.
Last updated November 10, 2026
Understanding Dupuytren's Contracture
Dupuytren's contracture is a slow, benign fibrosis of the palmar fascia, the tough sheet of tissue just under the skin of the palm that anchors the skin and lets you grip. It begins as a firm pea-sized nodule, usually at the base of the ring or little finger, and over years can mature into a rope-like cord that draws the finger toward the palm. It is one of the most heritable conditions in medicine: a Danish twin study put heritability at about 80 percent, and genome studies have found more than two dozen risk variants. In northern European populations the numbers are striking, with pooled prevalence rising from about 12 percent at 55 to 21 percent at 65 and 29 percent at 75. In the United States estimates run from about 1 to 7 percent of adults depending on how carefully hands are examined. Men are affected several times more often than women and roughly a decade earlier. Diabetes roughly doubles the risk, and smoking, heavy drinking, epilepsy medications and years of vibrating tools are each associated with it.
Under the microscope the nodule is a cluster of myofibroblasts, contractile cells normally seen in healing wounds, laying down disorganized type III collagen under the influence of growth factors such as TGF-beta. Over months to years the nodule matures: cells thin out, collagen aligns along lines of tension, and what remains is a relatively acellular cord that shortens. Cords form along predictable paths, and one variant, the spiral cord, wraps around and displaces the digital nerve, which is why procedures carry a small risk of nerve injury. Where the cord crosses matters more than how long it is: a contracture at the knuckle (MCP) joint is correctable even when severe, while a contracture at the middle (PIP) joint stiffens the joint capsule within months and is never fully corrected once it passes about 60 degrees. The disease is usually painless, although early nodules can itch or be tender. Progression is unpredictable: in one 9-year follow-up of people with nodules alone, only about half developed a cord and fewer developed a contracture that needed treatment.
Treatment is offered when function is affected, usually a knuckle contracture of 30 degrees or more, any progressive PIP contracture, or failure of the tabletop test, in which you cannot lay the palm and fingers flat. Three procedures dominate, and they trade durability against invasiveness. Needle aponeurotomy divides the cord through the skin under local anesthetic in minutes, with normal use within days; in a Dutch randomized trial it corrected contractures as well as surgery at first, but recurrence at 5 years was 85 percent versus 21 percent after limited fasciectomy. Collagenase injection (Xiaflex) dissolves the cord so the finger can be straightened a day or two later; in the 308-patient CORD I trial 64 percent of cords reached near-full correction versus 7 percent with placebo, 77 percent at MCP joints but only 40 percent at PIP joints, with 47 percent recurrence at 5 years. A Swedish trial of 140 patients found collagenase and needle release gave essentially the same results at 1 and 2 years. Limited fasciectomy, surgical removal of the diseased fascia, is the most durable and the most involved: 6 to 12 weeks of recovery, hand therapy, and complications in roughly 1 in 5, including nerve injury, infection, stiffness and complex regional pain syndrome. Dermofasciectomy with a skin graft is reserved for aggressive or recurrent disease.
No supplement, cream or diet slows, softens or reverses Dupuytren's, and vitamin E is the clearest example of a remedy that was tested and failed. Reports in the 1940s claimed oral vitamin E dissolved cords; controlled trials in 1949 and 1952, giving 200 to 300 mg a day for months, found no measurable change in contracture, and nobody has shown otherwise since. N-acetylcysteine, curcumin, magnesium, DMSO, allopurinol, colchicine, PABA (Potaba) and topical verapamil circulate online on the strength of test-tube studies, case reports or extrapolation from Peyronie's disease; none has a controlled trial in Dupuytren's. Stretching, massage and night splints do not prevent a cord from forming because a mature cord is collagen, not muscle, and forceful stretching can inflame nodules. A randomized trial of 154 patients even found routine night splinting after fasciectomy added nothing to therapy alone. Where natural approaches honestly fit is in the risk factors you can move: stopping smoking, keeping alcohol moderate, and keeping an A1c in range if you have diabetes, each of which is associated with less severe disease and better healing after any procedure. Watchful waiting for a painless nodule is itself the most evidence-based option there is.
The most common mistake is the opposite of what people fear: not treating too early, but waiting too long with the wrong joint. People with a bent ring finger often cope for years, and a knuckle contracture usually forgives that delay, but a PIP joint bent beyond 60 degrees cannot be fully straightened by any method, and recurrence is higher. If the middle joint of the finger is bending, see a hand surgeon now rather than at the next physical. The second mistake is choosing a procedure on recurrence rates alone. Needle release recurs more often but can be repeated in an office visit with almost no downtime, which suits an 80-year-old with a knuckle contracture; a 50-year-old with disease in both hands and a family history may be better served by fasciectomy. The third is spending months on splints, creams and supplements for a nodule that may never progress; photograph the hand, repeat the tabletop test monthly and let the finger, not the internet, decide when to act. Ask any surgeon you see whether they offer all three procedures; a surgeon who offers only one tends to recommend it.
At a Glance
- Common symptoms
- One or more firm lumps or nodules in the palm, usually near the base of the ring or little finger, Thickened, puckered or dimpled skin over the palm, A tough cord of tissue extending from the palm into a finger
- Main treatments
- Observation for nodules and mild contractures that do not interfere with hand function, Needle aponeurotomy, in which a needle is used to divide the cord through the skin, a quick procedure with fast recovery, Collagenase enzyme injection into the cord to weaken it so the finger can be straightened a day or two later (availability varies by country)
- Category
- Musculoskeletal · Common in older men of northern European descent; less common in other populations
- See a doctor if
- A lump in the palm or a finger that is starting to bend and cannot be fully straightened
Symptoms
Causes
- Abnormal thickening and contraction of the palmar fascia by overactive fibroblast cells, the cause of which is not fully understood
- Strong genetic predisposition, with many affected people having a family history
- Possible contributing factors such as diabetes, which increases risk
- Associations with smoking, alcohol excess and certain seizure medications
- Repeated hand trauma or vibration exposure may play a role in some people, though evidence is mixed
Risk Factors
- Being male; men are affected far more often and more severely
- Age over 50
- Northern European or Scandinavian ancestry
- A family history of Dupuytren's
- Diabetes
- Smoking and heavy alcohol use
Diagnosis
- Physical examination of the palm and fingers for nodules, cords and skin changes
- The tabletop test: whether you can place your palm and fingers flat on a table
- Measurement of how far each affected finger joint is bent
- Imaging is rarely needed; ultrasound is occasionally used to assess the cords
Treatment
- Observation for nodules and mild contractures that do not interfere with hand function
- Needle aponeurotomy, in which a needle is used to divide the cord through the skin, a quick procedure with fast recovery
- Collagenase enzyme injection into the cord to weaken it so the finger can be straightened a day or two later (availability varies by country)
- Surgery (fasciectomy) to remove the diseased tissue for severe or recurrent contractures
- Hand therapy and splinting after any procedure to maintain the straightened position
- Supportive: hand stretching and massage may ease stiffness but do not prevent the contracture from progressing
- Supportive: managing diabetes well and stopping smoking
What matters day to day
- Stop smoking: smokers are two to three times more likely to develop Dupuytren's and heal less well after hand surgery because nicotine constricts the small vessels of the palm.
- Keep alcohol moderate and, if you have diabetes, keep your A1c in range: both heavy drinking and poorly controlled diabetes are associated with earlier, more extensive disease and with more complications after procedures.
- Do the tabletop test on the first of each month and photograph your open hand from above in the same spot: a written record of when the palm stopped going flat, and of the angle at the knuckle and middle joint, tells a surgeon far more than memory.
- Pad the pressure points rather than avoiding use: padded cycling or work gloves and thicker tool handles take pressure off tender nodules, while normal daily hand use neither causes nor worsens the contracture.
- Do not force the finger straight: aggressive stretching of a cord does not lengthen it and can inflame the nodule; save the work for after a procedure, when the exercises and any splint your hand therapist prescribes set most of the final result.
- After any procedure, follow the therapy plan for the full 3 months: that window, when the tissue is healing, determines how much of the correction you keep, and it is where most avoidable stiffness happens.
Prevention
- There is no proven way to prevent Dupuytren's contracture
- Stopping smoking and moderating alcohol may reduce risk and severity
- Keep diabetes well controlled
- Monitor nodules and seek treatment before the finger becomes severely bent, when outcomes are better
- Protect the hands from heavy vibration where possible
When to See a Doctor
- A lump in the palm or a finger that is starting to bend and cannot be fully straightened
- You can no longer lay your hand flat on a table
- Difficulty with everyday tasks such as putting your hand in a pocket, washing or wearing gloves
- Rapid progression or involvement of several fingers
- Painful nodules, which can be assessed to rule out other causes
Frequently Asked Questions
References
- Hurst LC, Badalamente MA, Hentz VR, et al.; CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. New England Journal of Medicine (2009)
- Peimer CA, Blazar P, Coleman S, et al.. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 5-year data. Journal of Hand Surgery (American) (2015)
- van Rijssen AL, ter Linden H, Werker PMN. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plastic and Reconstructive Surgery (2012)
- Stromberg J, Ibsen-Sorensen A, Friden J. Comparison of treatment outcome after collagenase and needle fasciotomy for Dupuytren contracture: a randomized, single-blinded, clinical trial with a 1-year follow-up. Journal of Bone and Joint Surgery (American) (2016)
- Lanting R, Broekstra DC, Werker PMN, van den Heuvel ER. Prevalence of Dupuytren disease in the Netherlands and a systematic review of prevalence in Western countries. Plastic and Reconstructive Surgery (2014)
- Larsen S, Krogsgaard DG, Aagaard Larsen L, et al.. Genetic and environmental influences in Dupuytren's disease: a study of 30,330 Danish twin pairs. Journal of Hand Surgery (European Volume) (2015)
- Jerosch-Herold C, Shepstone L, Chojnowski AJ, et al.. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskeletal Disorders (2011)
- King RA. Vitamin E therapy in Dupuytren's contracture: examination of the claim that vitamin therapy is successful. Journal of Bone and Joint Surgery (British) (1949)
- Richards HJ. Dupuytren's contracture treated with vitamin E. British Medical Journal (1952)
- Nanchahal J, Ball C, Rombach I, et al.. Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial. Lancet Rheumatology (2022)
- Mayo Clinic. Dupuytren contracture (2024)View source
Related Conditions
Have questions about Dupuytren's Contracture?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.